IP Library Granted Patent US 11,878,068
Granted Patent B2
US 11,878,068 · App. 17/699,272 · Granted Jan 23, 2024

Electromagnetic radiation and delivery carrier for oral care

Inventors: Jayanth Rajaiah (Loveland, OH); Paul Albert Sagel (Mainville, OH); Franco Silva Medeiros (Loveland, OH)
Assignee: The Procter & Gamble Company
A61K8/064A61C19/066A61K8/0216A61K8/062A61K8/22A61K8/31A61K8/345A61K8/8111A61K8/86A61K8/92A61N5/062A61N5/0603A61Q11/00A61Q11/02A61K2800/42A61K2800/81A61K2800/87A61K2800/884A61K2800/92A61N2005/0606A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,878,068
App. No.
17/699,272
Granted
Jan 23, 2024
Kind
B2
Abstract

Delivery carriers having multi-phase oral compositions used with an electromagnetic radiation source for whitening teeth.

Claims (27)

1. A kit comprising:

a) a delivery carrier,

b) a multi-phase oral composition for whitening teeth, comprising:

i. from about 0.002% to about 30% by weight of the multi-phase oral composition of an aqueous phase having a bleaching agent, wherein a concentration of the bleaching agent is up to 10%, by weight of the multi-phase oral composition;

ii. a hydrophobic phase having a cone penetration consistency value of from about 50 to about 500, as measured by ASTM D937-07,

wherein the multi-phase oral composition is a water-in oil emulsion, and

wherein the hydrophobic phase is a predominant portion of the multi-phase oral composition; and

c) an electromagnetic radiation source capable of directing electromagnetic radiation with one or more wavelength in the range from about 200 nm to about 1700 nm toward at least one tooth.

2. The kit according to claim 1 , wherein a ratio of a concentration in weight percent of bleaching agent present in the aqueous phase to a concentration in weight percent of bleaching agent present in the multi-phase oral composition is at least about 5.

3. The kit according to claim 2 , wherein the ratio is at least about 10.

4. The multi-phase oral composition according to claim 1 , wherein an amount of the bleaching agent ranges from about 0.01% to about 5%, by weight of the multi-phase oral composition.

5. The multi-phase oral composition according to claim 1 , wherein the cone penetration consistency value of the hydrophobic phase is from about 100 to about 300, as measured by ASTM D937-07.

6. The multi-phase oral composition according to claim 5 , wherein the cone penetration consistency value of the hydrophobic phase is from about 100 to about 250, as measured by ASTM D937-07.

7. The multi-phase oral composition according to claim 1 , wherein a drop melting point of the hydrophobic phase is from about 40° C. to about 80° C., as measured by ASTM D127-08.

8. The multi-phase oral composition according to claim 1 , wherein a two-dimensional density of droplets with a cross-sectional area larger than about 10000 square microns measured using the procedure specified herein is no more than about 20 per square centimeter.

9. The multi-phase oral composition according to claim 8 , wherein a two-dimensional density of droplets with a cross-sectional area larger than about 10000 square microns measured using the procedure specified herein is no more than about 10 per square centimeter.

10. The multi-phase oral composition according to claim 1 , wherein a standard deviation of a peroxide intensity of the multi-phase oral composition smeared onto peroxide test strips measured using the procedure specified herein is no more than about 50.

11. The multi-phase oral composition according to claim 10 , wherein the standard deviation of the peroxide intensity of the multi-phase oral composition smeared onto peroxide test strips measured using the procedure specified herein is no more than about 25.

12. The multi-phase oral composition according to claim 1 , wherein a mean peroxide intensity of the multi-phase oral composition smeared onto peroxide test strips measured using the procedure specified herein is from about 1 to about 100.

13. The multi-phase oral composition according to claim 1 , wherein a mean residual peroxide intensity of the multi-phase oral composition smeared on teeth measured using the procedure specified herein is from about 20 to about 200.

14. The multi-phase oral composition according to claim 1 , wherein the bleaching agent comprises hydrogen peroxide.

15. The multi-phase oral composition according to claim 1 , wherein the hydrophobic phase comprises at least one of: mineral oil thickened with wax, mineral oil thickened with polyethylene, or petrolatum.

16. The multi-phase oral composition according to claim 1 , wherein a bleaching efficacy of the multi-phase oral composition calculated as −Δb* and measured per the clinical protocol as disclosed herein is at least about 1.5.

17. The multi-phase oral composition according to claim 1 , wherein a ratio of a bleaching efficacy of the multi-phase oral composition calculated as −Δb* and measured per the clinical protocol as disclosed herein to a weight percentage of bleaching agent present in the multi-phase oral composition is at least about 1.5.

18. The multi-phase oral composition according to claim 1 comprising a delivery carrier.

19. The multi-phase oral composition according to claim 18 wherein the delivery carrier is a strip.

20. The kit for whitening teeth according to claim 18 , wherein the electromagnetic radiation source emits electromagnetic radiation in the range from about 400 nm to about 500 nm, impinging on the outer surface of the delivery carrier at least one tooth, in the range from about 175 mW/cm 2 to about 225 mW/cm 2 measured using the procedures described herein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2022
From: RAJAIAH, JAYANTH NMN; SAGEL, PAUL ALBERT; MEDEIROS, FRANCO SILVA
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 059331/0142 →
Continuity (9)
Continuation 15790903 · Oct 23, 2017
Provisional Application 62413189 · Oct 26, 2016
Provisional Application 62413200 · Oct 26, 2016
Provisional Application 62413205 · Oct 26, 2016
Provisional Application 62413214 · Oct 26, 2016
Provisional Application 62413222 · Oct 26, 2016
Provisional Application 62413229 · Oct 26, 2016
Provisional Application 62413237 · Oct 26, 2016
Related Publication 20220280397A1 · Sep 8, 2022
Cited By (1)
US 12,337,044